Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Cytokinetics To Announce First Quarter Results On April 27, 2017 April 13, 2017 Gene-Editing Leader Horizon Discovery to Go on Global Hiring Spree April 30, 2017 Don't Count Us Out: Pfizer Hints at a Possible Bristol-Myers Squibb Deal May 2, 2017